On Monday, Martin Marietta got a positive adjustment to its Relative Strength (RS) Rating, from 70 to 73.
IBD's proprietary RS Rating measures technical performance by using a 1 (worst) to 99 (best) score that indicates how a stock's price performance over the trailing 52 weeks compares to the rest of the market.
History reveals that the best-performing stocks often have an RS Rating of over 80 as they launch their largest runs. See if Martin Marietta can continue to show renewed price strength and clear that threshold.
When To Sell Stocks To Lock In Profits And Minimize Losses
Martin Marietta is working on a flat base with a 626.67 buy point. See if it can break out in heavy volume.
In terms of fundamentals, Martin Marietta has posted rising EPS growth over the last three quarters. Revenue gains have been less impressive, coming in at -8% in the latest report.
Martin Marietta holds the No. 2 rank among its peers in the Building-Cement/Concrete/Aggregates industry group. U.S. Lime & Minerals is the top-ranked stock within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
